Polycystin 2-type cation channels PKD2 and PKD2L1 interact with polycystin 1-type proteins PKD1 and PKD1L3 respectively, to form receptor-cation-channel complexes. The PKD2L1-PKD1L3 complex perceives sour taste, whereas disruption of the PKD2-PKD1 complex, responsible for mechanosensation, leads to development of ADPKD (autosomal-dominant polycystic kidney disease). Besides modulating channel activity and related signalling events, the CRDs (C-terminal regulatory domains) of PKD2 and PKD2L1 play a central role in channel oligomerization. The present study investigates the aggregation state of purified full-length PKD2L1-CRD as well as truncations of CRDs from PKD2 channels. Far-and near-UV CD spectroscopy show that the full-length PKD2L1 CRD (PKD2L1-198) and the truncated PKD2 CRD (PKD2-244) are α-helical with no β-sheet, the α-helix content agrees with sequence-based predictions, and some of its aromatic residues are in an asymmetric environment created at least by partially structured regions. Additionally, the CRD truncations exhibit an expected biochemical function by binding Ca 2+ in a physiologically relevant range with K d values of 2.8 μM for PKD2-244 and 0.51 μM for PKD2L1-198. Complimentary biophysical and biochemical techniques establish that truncations of the PKD2 and PKD2L1 CRDs are elongated molecules that assemble as trimers, and the trimeric aggregation state is independent of Ca 2+ binding. Finally, we show that a common coiled-coil motif is sufficient and necessary to drive oligomerization of the PKD2 and PKD2L1 CRD truncations under study. Despite the moderate sequence identity (39 %) between CRDs of PKD2 and PKD2L1, they both form trimers, implying that trimeric organization of CRDs may be true of all polycystin channels.
INTRODUCTION
Polycystins are transmembrane proteins that form a distinct subgroup of the TRP (transient receptor potential) superfamily of channels [1, 2] . Within polycystins, two subfamilies, exemplified by PKD1, or TRPP1, and PKD2, or TRPP2, are recognized. Although channel activity has not been demonstrated for PKD1, it has eleven transmembrane segments of which the last six are similar to both PKD2 and other voltage-gated Ca 2+ channels [3, 4] . PKD2 assembles with PKD1 to form a functional Ca 2+ -permeable cation channel complex in the plasma membrane [5] and the primary cilium [6] . In addition to currents observed at the plasma membrane in conjunction with PKD1, PKD2-mediated channel activity has also been shown in other subcellular membranes where it acts as an intracellular Ca 2+ release channel [7] [8] [9] . Interactions between PKD1 and PKD2 are driven by their cytoplasmic C-terminal regions [5, [10] [11] [12] . PKD1-PKD2 interactions are critical to kidney architecture and function because complex-disrupting mutations in either partner lead to development of ADPKD (autosomal-dominant polycystic kidney disease), which affects 1 in 1000 individuals [13, 14] .
Cation channel activity of polycystins was first demonstrated using PKD2L1, or TRPP3, which has 50 % sequence identity over its entire length with PKD2 [15] . PKD2L1 interacts with the PKD1 homologue PKD1L3 to form a novel receptor-ionchannel complex that detects sour taste via low pH [16, 17] . In the absence of PKD1L3, however, the PKD2L1 channel responds to changes in cerebrospinal fluid at a more physiological pH, detecting CO 2 levels and assisting in homoeostasis [18] in the neurons surrounding the central canal of the spinal cord. There is also a reported interaction of PKD2L1 with PKD1, although the functional role of such a complex is unclear [19] . Although PKD2L1 is not implicated in ADPKD, mice lacking the gene for the PKD2L1 homologue exhibit other kidney and eye defects [20] .
Polycystin channels, including PKD2 and PKD2L1, share a conserved architecture of a central pore-forming region consisting of six transmembrane segments flanked by a poorly conserved N-terminal region and a regulatory domain at the C-terminus. This CRD (C-terminal regulatory domain) plays a variety of roles that affect subcellular trafficking, protein-protein interactions, signalling and channel conductance [21] [22] [23] [24] . CRDs of PKD2 and PKD2L1 have EF-hand Ca 2+ -binding motifs that may be involved in the observed intracellular Ca 2+ -dependent activation of the channel [9, 15, 22, 25] . PKD2 742X, a naturally occurring pathogenic mutant lacking the EF-hand, does not display Ca 2+ activation [26] . Additionally, phosphorylation of Ser 812 in the PKD2 CRD modulates the Ca 2+ -dependent activation of the channel [25] . The interaction of the PKD2 CRD with the C-terminal tail of PKD1 exerts a mutual regulatory effect on the function of both proteins. The constitutive activation of heterotrimeric G-proteins by the PKD1 C-terminal tail is antagonized by its interaction with the PKD2 CRD [27, 28] , whereas the PKD1 C-terminal tail stabilizes PKD2 channel activity [29] . In addition to interactions with PKD1, PKD2 CRD also associates with the isolated C-terminal region of TRPC1 (TRP channel C1) [30] , and recent studies show formation of heteromeric channels with both TRPC1 and TRPV4 (TRP channel V4) that exhibit unique conductance properties [31, 32] . Finally, a
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role for the CRD in PKD2 oligomerization has been demonstrated using both isolated and membrane-tethered versions of PKD2 CRD [11,12,32a,32b] . Although the physiological role of the PKD2L1-PKD1 complex is yet to be determined, the CRD of PKD2L1 is necessary for interaction with PKD1 and trafficking to the plasma membrane [33] . Recently, conflicting studies have emerged regarding the oligomerization state of the PKD2 CRD [32a,32b] . To clarify this matter, in the present study we examined the oligomerization state of both PKD2 CRD and that of the closely related PKD2L1.
As PKD2 and PKD2L1 CRDs play a central role in a large number of processes mediated by the full-length channels, studies were conducted to characterize the biochemical and biophysical properties of the PKD2 and PKD2L1 CRDs, address the stoichiometry of assembly and identify the region responsible for oligomerization. A common aggregation state for the CRDs may be significant to the organization of the pore domains of PKD channels.
EXPERIMENTAL

Cloning
Sequences encoding CRD truncations of murine PKD2 (GenBank ® accession number NP032887) and human and murine PKD2L1 (GenBank ® accession numbers BC116297 and BC116323.2 respectively) were cloned into the pMALP2 or pGSTP1 expression vectors [34] to facilitate production of CRDs fused to either MBP (maltose-binding protein) or GST (glutathione transferase) respectively. Figure 1 shows the boundaries of truncations used in the present study. Clones were confirmed by DNA sequencing.
Expression
PKD2
CRDs of various lengths were expressed in Escherichia coli BL21(DE3) Rosetta 2 PLysS cells (Novagen). Upon reaching a D 600 of 0.6 at 37
• C in LB (Luria-Bertani) medium, the cultures were cooled and expression induced with 0.5 mM IPTG (isopropyl β-D-thiogalactoside), then cultures were incubated overnight at 18
• C. The full-length (murine PKD2L1-198) and other PKD2L1 CRD truncations were expressed as described above; however, cells were harvested after 6 h at 18
• C, as degradation was observed after longer incubation periods. Only murine PKD2L1-198 was expressed as a GST-fusion protein because of significantly higher protein yields. All other PKD2L1 truncations were derived from human cDNA and expressed as MBP-fusion proteins owing to greater stability and more consistent yields.
Purification
To purify MBP-fusion proteins, cells from 1 litre of culture were resuspended in 45 ml of buffer A [20 mM Hepes (pH 7.6), 200 mM NaCl, 10 mM KCl, 10 % (v/v) glycerol and 10 mM 2-mercaptoethanol] containing 0.1 mg of DNase, protease inhibitor cocktail (Sigma-Aldrich) and 1 mM PMSF, and then lysed by sonication. The MBP-fusion proteins were isolated from the clarified lysate by binding to 20 ml of pre-equilibrated amylose resin (New England Biolabs) for 45 min. The resin with protein bound was then packed into a 2.5 cm × 20 cm Econo-column (Bio-Rad) and washed with 200 ml of buffer A, followed by elution with 45 ml of buffer A containing 10 mM maltose.
To purify the GST fusion of murine PKD2L1-198, cells from 2 litres of culture were resuspended in 45 ml of PBS buffer [140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 (pH 7.3), 10 % (v/v) glycerol and 10 mM 2-mercaptoethanol] containing 0.1 mg of DNase, protease inhibitor cocktail and 5 mM PMSF, and then lysed by sonication. Protein was purified from the clarified lysate by binding to a 5 ml GS-Trap HP column (GE Healthcare) in PBS, washing with 10 column volumes of PBS , and eluted with 50 mM Tris/HCl (pH 8.0) containing 10 mM GSH, 10 mM 2-mercaptoethanol and 10 % (v/v) glycerol. All steps were carried out at a flow rate of 2.0 ml/min. After elution from the glutathione column, NaCl was added to a final concentration of 200 mM.
In the cases where the MBP-fusion tag was removed (PKD2-244, PKD2-175, PKD2-159, PKD2-112 and PKD2-92), an overnight digestion at 4
• C with a 1:100 mass ratio of TEV (tobacco etch virus) protease was performed. The MBP moiety was retained on the truncations MBP-PKD2-38, MBP-PKD2-93, MBP-PKD2L1-111, MBP-PKD2L1-124 and MBP-PKD2L1-50 for ease of manipulation. Where relevant, the CRD truncations were separated from MBP using anion-exchange chromatography on a 5 ml HiTrap Q HP column (GE Healthcare) with binding buffer comprising 20 mM Tris/HCl (pH 8.0), 20 mM NaCl, 10 % (v/v) glycerol, 10 mM 2-mercaptoethanol, and elution buffer comprising 20 mM Tris/HCl (pH 8.0), 1 M NaCl, 10 % (v/v) glycerol and 10 mM 2-mercaptoethanol at a flow rate of 2 ml/min. In all cases (regardless of MBP retention or removal) the final step of purification was size-exclusion chromatography on a HiLoad 16/60 Superdex 200 column (GE Healthcare) in buffer A at 1.0 ml/min. All purification steps were carried out at 4
• C. For PKD2L1-198, TEV protease digestion, separation from GST and size-exclusion chromatography were carried out as described for MBP fusions.
Determination of protein concentration
Protein was quantified by measuring the absorbance at 280 nm using molar absorption coefficients (ε) of 9970 and 15427 M −1 · cm −1 for purified PKD2-244 and PKD2L1-198 respectively. These concentrations were confirmed using the Bradford assay (Bio-Rad).
CD spectroscopy
Near-and far-UV spectral measurements were carried out with a J-810 spectropolarimeter (Jasco). For far-UV experiments, spectra were collected at 25
• C from 250 to 190 nm using a quartz cuvette with a 0.1 mm optical path, with a 0.5 nm step size, 2 nm bandwidth and 2 s averaging time. Three scans were accumulated for each data set, and buffer-subtraction was used to correct the spectra. Proteins were assayed at 1.1 mg/ml (37 μM) for PKD2-244 and 0.9 mg/ml (39 μM) for PKD2L1-198 in 10 mM KH 2 PO 4 , 1.8 mM Na 2 HPO 4 (pH 7.5) and 5 mM KCl. This phosphate buffer with low chloride content was used for the far-UV CD experiments because both Hepes and chloride absorb strongly in the far-UV range and can interfere with data collection at values less than 220 nm [35] . Fractional helical content was calculated from the molar ellipticity at 222 nm using the program K2D2 [36] and compared with the theoretical helical content calculated from primary sequence by the PROFsec program in the PredictProtein suite using default parameters [37] . Near-UV measurements from 340 to 260 nm were conducted in a 1 cm path-length quartz cuvette at the same temperature and collection parameters as the far-UV data sets. Protein concentrations used were 1.1 mg/ml (37 μM) for PKD2-244 and 1.2 mg/ml (51 μM) for PKD2L1-198. Measurements of folded proteins were conducted in a buffer containing 20 mM Hepes (pH 7.6), 200 mM NaCl and 1 mM CaCl 2 . To denature the proteins, purified samples were dialysed against buffer containing 6 M guanidinium-HCl, 20 • C in a 1 cm × 1 cm quartz cuvette with mixing. To determine Ca 2+ -binding constants, aliquots of Quin 2 were repeatedly titrated into 2 ml of protein solution, allowing 2 min for equilibration between additions. The removal of Ca 2+ from the protein by Quin 2 was monitored by integrating the fluorescence intensity of Quin 2, excited at 339 nm, over the range 450-530 nm. The bandwidth of excitation and emission was 4 nm, and the spectrum was scanned at 1 nm/s with a resolution of 1 nm. Fluorescence intensity (F) was calculated by subtracting a buffer-alone baseline spectrum from the emission curve for each Quin 2 addition, then integrating the area under the curve from 450 to 530 nm. Three data sets for each CRD were collected and averaged with the S.D. among data sets indicated by error bars in Figure 3 (A). K d (app) values were determined from the best fit of eqn 1:
where C is the Ca 2+ concentration (bound Ca 2+ from ICP-MS measurements described above as the initial parameter), x is the Quin 2 concentration and V is the maximum F. K d (app) values were then used in eqn 2:
where K Q is the known K d value for Quin 2 under the buffer conditions above (120 nM), K P is the K d value to be determined experimentally for the CRD and P is the protein concentration of each sample as listed above.
SLS (static light scattering)
Purified proteins at 1.0 mg/ml (33 and 43 μM for PKD2-244 and PKD2L1-198 respectively) were passed through an HR 10/30 Superdex 200 column (GE Healthcare) connected to in-line laser light scattering, refraction index and UV detectors (Wyatt Technology) at the Keck Biophysics Facility at Yale University. The system was equilibrated in the Biophysics Core Facility standard buffer containing 20 mM Hepes (pH 8.0), 150 mM NaCl and 1 mM EDTA. All experiments were performed at room temperature (23 • C). The data were analysed using ASTRA software (Wyatt Technology).
Analytical ultracentrifugation
SV (sedimentation velocity) experiments using PKD2-244 and PKD2L1-198 were conducted using a Beckman Optima XL-I ultracentrifuge (Beckman-Coulter). Carbon-filled epon twosector 1.2 cm centrepieces and sapphire windows were used for all experiments. Proteins were dialysed against 20 mM Tris/HCl (pH 7.5). The density and viscosity of the solvents and partial specific volumes for the proteins under study were calculated using the program SEDNTERP (http://www.jphilo. mailway.com). Vbar values used were 0.720 and 0.726 for PKD2-244 and PKD2L1-198 respectively, with a buffer density of 1.0 g/ml. All experiments were conducted in an An60 Ti four-hole rotor using both absorbance and interference detection systems. The cell and rotor were maintained under vacuum at 0 rev./min for at least 1 h prior to the start of each run to attain thermal equilibrium at 20
• C. The centrifuge was started from 0 rev./min and data collection began immediately, with 100 scans collected at 1.5-5 min intervals depending on the number of cells scanned. The final rotor speed was 50 000 rev./min. Data were analysed using the software packages Sedfit (version 11.8) and Sedphat (version 6.5) [40] [41] [42] .
Cross-linking and MS
CRD truncations at concentrations ranging from 0.05 to 0.15 mg/ml (1.6-6.5 μM) in buffer A were cross-linked by the addition of 0.5-2.5 mM glutaraldehyde, an amine-reactive crosslinking reagent. The reaction was allowed to proceed for 30 min at room temperature before quenching with a final concentration of 10 mM Tris/HCl (pH 8.0). Then, 10 μg of cross-linked product was loaded on to SDS/PAGE (4-20 % gels) and visualized by Coomassie Blue staining. The molecular mass of crosslinked products was confirmed by MALDI (matrix-assisted laserdesorption ionization)-MS. In the case of analyses conducted in the absence of Ca 2+ , samples at 0.2 mg/ml were treated with 100 mM EDTA for 30 min while incubating on ice. To remove EDTA, 1 ml of each sample was then passed over a Sephadex G-25 NAP-10 column pre-equilibrated with Chelex-100-treated saturated NaCl solution. Samples were eluted in 1.2 ml of Chelex-100-treated buffer A. Samples were then dialysed overnight against the elution buffer to remove excess NaCl and any residual EDTA prior to cross-linking.
Size-exclusion chromatography
Size-exclusion analyses of PKD2 and PKD2L1 truncations were performed at room temperature with an HR 10/30 Superdex 200 column (GE Healthcare) in buffer A at a flow rate of 0.5 ml/min. The position of protein elution was identified by continuously monitoring absorbance at 280 nm. Samples analysed in the absence of Ca 2+ were pre-treated on ice with 100 mM EDTA for 30 min before proceeding with size-exclusion in buffer A with 10 mM EDTA.
RESULTS
Purified CRD truncations are homogeneous and have structured regions
A number of truncations of the PKD2 and PKD2L1 CRDs were purified from E. coli to homogeneity. Folding of recombinantly expressed, purified PKD2-244 and PKD2L1-198 was evaluated using far-UV and near-UV CD spectroscopy to provide information on secondary and tertiary protein structure. Both PKD2-244 and PKD2L1-198 are largely α-helical (50 % and 48 % respectively), as indicated by double minima in both spectra at 208 and 222 nm, with no detectable β-sheet content ( Figure 2C ). The α-helical content determined experimentally is in good agreement with values predicted from the primary sequence using bioinformatics software [37] , which also suggests a lack of β-sheet structure. Near-UV CD measurements in the range 340-260 nm can be used to determine whether the protein under study has a defined structure based on the environment surrounding aromatic residues, which are the chromophores in this wavelength range. Owing to their hydrophobic character, aromatic residues tend to be buried in a folded protein, and thus are surrounded by an asymmetric environment, which gives rise to non-zero values in the 340-260 nm region. A approximately baseline readout, conversely, indicates that the aromatic residues are in a symmetrical environment, suggesting that the residues are uniformly exposed to solvent as in an unfolded protein. Native protein and protein unfolded by 6 M guanidiniumHCl was studied in the near-UV range from 340 to 260 nm. The non-zero values of molar ellipticity in the 300-260 nm range for proteins in the native state indicates that the aromatic residues in the proteins are in an asymmetric environment ( Figure 2D ). In contrast, the guanidinium-HCl-unfolded proteins yield baseline spectra with little or no signal from aromatic residues. Taken together, these CD data indicate that the PKD2-244 and PKD2L1-198 have an appropriate secondary structure and aromatic residues located in structured regions.
Purified CRDs bind Ca
2+
In order to determine the binding constant of Ca 2+ to PKD2-244 and PKD2L1-198, a fluorescence assay using the competitive chelator Quin 2, a small molecule that binds Ca 2+ tightly (K d = 120 nM at physiological concentrations of KCl), was used. Fluorescence changes upon titration of Quin 2 into solutions containing PKD2 (30 μM; left-hand panel) or PKD2L1 (27 μM; right-hand panel) and their respective dialysis buffers are shown in Figure 3 . Comparison of these curves reveals that Quin 2 has a much greater quantum fluorescence increase in the samples containing protein, indicating that there is substantially more Ca 2+ bound to the proteins than free in buffer solution. Fitting of these curves reveals that Ca 2+ binds to PKD2-244 and PKD2L1-198 with K d values equal to 2.8 μM and 0.51 μM respectively.
CRDs self-associate to form trimers
To determine the oligomerization state of PKD2-244 and PKD2L1-198, three methods were employed. First, the monodispersity and oligomerization state of purified truncations in solution were studied using size-exclusion chromatography coupled to an in-line SLS analyser. In this case, the estimated mass of the protein sample is independent of the position of elution from a size-exclusion column, and therefore does not depend on the shape of the molecule. The elution profiles of PKD2-244 and PKD2L1-198 show single peaks at elution volumes of 11.8 and 12.6 ml respectively ( Figure 4A ). The molecular mass calculated across the peak for each sample is constant, indicating that the preparations are monodisperse. A comparison of the molecular masses calculated using light scattering data with those predicted from the sequence (69.2 and 85.9 kDa compared with 68.7 and 87.3 kDa for PKD2L1 and PKD2 respectively) show that both PKD2-244 and PKD2L1-198 are trimeric (Table 1) . SV analytical ultracentrifugation studies were used to further characterize the oligomeric state of PKD2-244 and PKD2L1-198. (Table 1) . Shape analysis based on frictional coefficients (f /f 0 ) calculated from SV data show that PKD2L1-198 and PKD2-244 have f /f 0 values of 1.83 and 2.14 respectively, which are much larger than those expected for globular proteins with masses equivalent to trimers (1.2-1.4). These data support our findings based on size-exclusion chromatography ( Figure 2B ) that the CRDs have elongated shapes.
Significant electrostatic influence as a result of primary charge effects may be present because PKD2-244 is highly anionic (−18/monomer) under salt-free conditions. Therefore we determined the effect of increasing salt on the sedimentation coefficient, S 0 20,w , by sedimenting PKD2-244 at 33 μM with NaCl concentrations ranging from 0 to 0.45 M ( Table 2 ). The increase in the sedimentation coefficient with increasing salt from 3.8 S at 0 mM NaCl to 4.1 S at 0.042 mM NaCl suggests a modest primary charge effect of approx. 8 % relative to the value at zero NaCl in Table 2 . Although there is considerable scatter in the calculated values of the weight-averaged mass, the values hover around the expected value for a trimer (87.3 kDa). Hence, the analytical ultracentrifugation data are consistent with a trimer that is clearly asymmetric in shape. In addition, a close inspection of the results in Table 2 suggests a weak formation of a larger molecule. A second smaller peak that has a sedimentation coefficient of approx. 5.6 S and constitutes approx. 10 % of the total mass present can be seen in the c(s) distribution plots for the high-salt data, but not at low-salt (results not shown). Such a process, if rapid on the experimental time scale, could partially explain why f /f 0 decreases with increasing salt as opposed to increasing because of the damping of charge repulsion between the macromolecules as the salt concentration increases. Based on single-molecule studies of the full-length complex in vivo [43] , where a trimer of PDK2 monomers is proposed, this higher-mass species is not physiologically relevant.
As seen in Table 1 , the value calculated for the PKD2L1-198 oligomeric mass by SV matches almost identically the value calculated from primary sequence (68.4 compared with 68.7 kDa). Because the results of the SV experiments confirmed that inclusion of salt did not substantially vary the initial findings that PKD2-244 was a trimer, and the trimeric oligomerization state of both PKD2-244 and PKD2L1-198 had been confirmed by other methods, we elected not to repeat the SV experiments with NaCl variation for PKD2L1-198 under these conditions.
To unambiguously identify the aggregation state of the CRD truncations, the purified proteins were chemically cross-linked using glutaraldehyde, and the cross-linked products were analysed by SDS/PAGE ( Figure 4C ) and MALDI-MS (Table 1) . Single bands of dissimilar mobility are observed when the samples are cross-linked with 2.5 mM glutaraldehyde as compared with the non-cross-linked sample ( Figure 4C, lanes 1 and 3) . At an intermediate concentration of glutaraldehyde (0.5 mM), multiple species are present, which can be interpreted as monomer, dimer, and either trimer or tetramer ( Figure 4C, lane 2) . At this intermediate glutaraldehyde concentration, the upper doublet band is likely to be a result of partial cross-linking, as MALDI-MS analysis of these samples reveals only three species corresponding with monomer, dimer and trimer. Fully cross-linked PKD2-244 and PKD2L1-198 ( Figure 4C, lane 3) have masses of 92.1 kDa and 70.4 kDa respectively, when analysed by MALDI-MS (Table 1) , which is three times the mass of the samples not treated with cross-linking agent.
A newly identified coiled-coil domain is sufficient and necessary for oligomerization of the PKD2 and PKD2L1 CRDs
Although there are no data to suggest the location of the PKD2L1 homo-oligomerization domain, previous work has suggested that the oligomerization of the PKD2 CRD is driven by a 24-26 residue coiled-coil motif [labelled CC1 (residues 772-796, numbering based on human PKD2 sequence) in Figure 5 ] [11] . However, such a region of 3.5 heptad repeats in length with a weak propensity to form coiled-coils may not be stable. That was contrary to our results showing formation of stable trimers at low protein concentrations (1.6 μM, the lowest concentration used in cross-linking experiments). Therefore additional analysis of the sequences of PKD2L1 and PKD2 using the program COILS [44] was conducted, resulting in identification of two additional coiled-coil domains, CC2 (residues 839-876) and CC3 (residues 881-922) (Figure 5 ). To investigate their relative contribution to oligomerization, regions representing the three coiled-coil motifs were expressed and purified. The conservation of these coiled-coil domains is illustrated in Figure 5 , whereas a schematic diagram representing the truncations used to identify the oligomerization determinants for the PKD2 and PKD2L1 CRDs can be found in Figure 1 . (Figures 1 and 7) reveal that its trimeric assembly is also driven by the CC2 domain. Truncations MBP-PKD2L1-124 (Phe 618 -Lys 741 ) and MBP-PKD2L1-50 (Gly 962 -Lys 741 ), which contain the CC2 region, form trimers, whereas MBP-PKD2L1-111 (Gln 579 -Gly 680 ), which contains only the CC1 region, is a monomer in solution ( Figure 7) . It is worthwhile to note that all truncations used in the present analysis were purified to homogeneity and exhibit unique aggregation states in size-exclusion chromatography, with their positions of elution corresponding to their respective oligomerization states (Figures 6 and 7) .
Because the overlap between the truncations capable of trimerizing (PKD2-175, PKD2-92 and MBP-PKD2-CC2 for PKD2; PKD2L1-124 and PKD2L1-50 for PKD2L1) is part of a five heptad canonical coiled-coil, and any truncation that lacks this CC2 region fails to oligomerize, we conclude that this region is both sufficient and necessary for oligomerization of the PKD2 and PKD2L1 CRDs.
Ca
2+ binding does not affect oligomerization of CRDs
While the present manuscript was in preparation, a publication by Schumann et al. [45] suggested a Ca 2+ -dependent change in Residues with >80 % conservancy are highlighted in black, residues that are >80 % similar are highlighted in grey. The proposed Ca 2+ -binding regions (731-744 and 761-764) are underlined with a striped bar; the first underlined section (731-744) was identified by Schumann et al. [45] . The PKD1-PKD2-interaction domain (874-893) is distinguished by a broken underline on the human PKD2 sequence. Heptad repeats (abcdefg) n that form coiled-coiled structures are labelled by showing positions of 'a' and 'd' residues. Boundaries of three putative coiled-coiled motifs CC1 (772-796), CC2 (839-876) and CC3 (881-922) with residue numbering based on human PKD2-CRD are shown using arrows, and the respective sequences are boxed in grey.
oligomerization of a truncation of PKD2-CRD containing the EF-hand and originally identified coiled-coil domain using NMR spectroscopy. To test this finding, we used a similar truncation named PKD2-112 (residues Ser 685 -Leu 796 ; Figure 1 ), in addition to truncations used previously, in a series of cross-linking and size-exclusion chromatography experiments in Ca 2+ -free buffers. Truncations that oligomerized previously (PKD2-244, PKD2-175, PKD2-92, MBP-PKD2-38 and PKD2L1-198) continued to display trimeric aggregation states, and a truncation that was monomeric in the presence of Ca 2+ (MBP-PKD2-93) remained monomeric upon removal of the ligand (Figure 8) . Additionally, PKD2-112 remained monomeric in the absence of Ca 2+ . Our analysis reveals that Ca 2+ has no effect on the oligomerization state of any of the truncations we have studied. As stated before, Quin 2 measurements of Chelex-treated buffer suggest that a small residual amount (0.4 μM) of Ca 2+ remains as opposed to untreated buffer (2.4 μM Ca 2+ ). However, the results from cross-linking in the Chelex-100-treated buffer are supported by the analytical sizeexclusion chromatography experiments performed in buffer A plus 10 mM EDTA, in which the effective free Ca 2+ concentration is 12.4 pM, which is far below the K d values for PKD2-244 and PKD2L1-198 (2.8 and 0.51 μM respectively). This suggests that the oligomerization states observed in this series of experiments represent those of ligand-free proteins. This conclusion is further supported by our SLS data, which demonstrate that PKD2-244 and PKD2L1-198 assemble into trimers in the presence of 1 mM EDTA (effective Ca 2+ concentration of 54 pM) ( Figure 4A ).
DISCUSSION
In the present study, our objectives were to determine the stoichiometry of self-assembly of PKD2 and PKD2L1 CRDs by studying truncations of the CRD regions and to elucidate the molecular determinants driving their oligomerization. These data are essential to define the rules that govern the formation of homomeric and heteromeric PKD2 and PKD2L1 channels and to understand the heteromeric protein-protein interactions mediated by CRDs that play a crucial role in trafficking, subcellular distribution, channel conductance and signalling [9, 25, [46] [47] [48] [49] . We conclude that CRD truncations derived from both PKD2 and PKD2L1 channels and the full-length murine PKD2L1 CRD (PKD2L1-198) assemble into trimers. This unexpected trimeric aggregation state is not an artefact, purified CRD truncations bind Ca 2+ at concentrations that are physiologically relevant, the α-helical content of the truncations tested matches that predicted from primary sequence, and the proteins have a structured core. Finally, we show that a highly conserved coiled-coil (CC2) is necessary and sufficient to drive self-assembly of PKD2 and PKD2L1 CRDs, and that Ca 2+ binding has no effect on oligomerization. Biochemical function was established by quantitative analysis of Ca 2+ binding to purified CRDs; a dissociation constant of 0.51 μM Ca 2+ indicates that PKD2L1-198 binds Ca 2+ with greater affinity when compared with PKD2-244 (2.8 μM). The higher affinity may be related to the absence in PKD2L1 of a residue equivalent to Ser 812 (human PKD2 numbering) and the regions proximal to Ser 812 in PKD2 channels ( Figure 5 ). Phosphorylation of Ser 812 significantly influences the Ca 2+ -dependent activation of PKD2 [25] . Both dephosphorylated wildtype PKD2 channels and S812A mutants require 10-fold higher concentrations of cytoplasmic Ca 2+ to reach the peak open probabilities achieved by wild-type phosphorylated channels [25] . The K d we report for Ca 2+ binding to PKD2-244 probably represents the binding constant for PKD2 lacking Ser 812 phosphorylation, as it is unlikely to be phosphorylated when expressed in a bacterial system. This K d value is close to that reported for a similar truncation of the PKD2 cytoplasmic domain by Celic et al. [50] (K d = 12.0 μM, determined using isothermal titration calorimetry) [50] . Previously, Schumann et al. [38, 45] [38, 45] with those calculated in the present study and that of Celic et al. [50] since the truncation used by Schumann et al. [38, 45] did not contain the CC2 domain found to be responsible for oligomerization.
Schumann et al. [38, 45] , using a truncation spanning Ile 680 -Leu 796 , containing the EF-hand and CC1 (but not the CC2), infer dimer formation based on line-broadening in 15 N-HSQC (heteronuclear single-quantum coherence) spectra in the absence of Ca 2+ and by comparing diffusion constants of the protein under study to a small-molecule standard. In contrast, the present studies suggest that Ca 2+ does not play a role in the oligomerization of PKD2-244, PKD2L1-198 or any of the other truncations tested, including PKD2-112 (Ile 680 -Leu 796 ) with boundaries similar to those used by Schumann et al. [38, 45] (Figure 1 ). It is likely that the reported dimerization may be due to the somewhat higher concentration of protein used in the experiments [50 μM for polycystin-2-(680-796) in NMR studies compared with 16 μM PKD2-112 in the present study]. Furthermore, the present study shows that CC2 is the major determinant in the trimeric assembly of CRD of PKD2 as well as for PKD2L1. Two other studies support our findings: a truncation (Gly 821 -Ser 926 ) lacking the EFhand in the study by Yu et al. [32a] assembles into trimers, and Bhen et al. [51] conclude that the full-length PKD2-CRD (Gly 679 -Val 968 ) forms trimers in the absence of Ca 2+ . The TRP superfamily of channels including PKD2 and PKD2L1 are proposed to assemble into homo-and/or heterotetramers with either PKD1-type or classical TRP proteins. Generally, hetero-oligomerization appears to be a selective process restricted to channels sharing a high level of primary sequence conservation (reviewed in [45] ). Notable exceptions are PKD2-TRPC1 and PKD2-TRPV4 interactions, wherein PKD2 is only distantly related to both TRPV4 and TRPC1 [1, 28, 29] . In the case of the PKD2-TRPC1 complex, both the CRD and parts of the transmembrane region contribute to heteromer assembly [30] . Heteromers of PKD2-TRPC1 and PKD2-TRPV4 have distinct conductance properties when compared with their homomeric counterparts [28, 29] , which raises the question of stoichiometry that could be 1:3, 2:2 or 3:1 within a tetrameric setting of the pore domain. On the basis of low-resolution structural studies using atomic force microscopy, PKD2 and TRPC1 are proposed to form a 2:2 complex when reconstituted in lipid bilayers [52] . We believe our data suggest a 3:1 stochiometry for PKD2 and TRPC1. Interestingly, the studies of Yu et al. [32a] conclude a 3:1 stochiometry for PKD2 and PKD1 heteromeric channels.
Using a number of biophysical techniques that have complementary strengths we show that isolated CRD truncations are trimers over a range of protein concentrations from 1.6 to 33 μM ( Figure 4 ). As such, trimeric PKD2 and PKD2L1 CRDs would introduce a symmetry mismatch in full-length channels between the tetrameric pore domain and the trimeric CRD. Nevertheless, in heteromeric channels formed by PKD2 and TRPC1 a 3:1 stoichiometry is plausible based on the observed 3A:1B arrangement in cyclic-nucleotide-gated channels consisting of A and B subtypes [53] [54] [55] . Whereas B subunits do not form functional homomeric channels, A subunits can be forced to form homotetramers by overexpression, whereas the 3A:1B arrangement is favoured under physiological levels of expression [53] . Likewise, formation of heteromers of PKD2 and other TRP subunits or PKD2L1 and PKD1L3 subunits at the plasma membrane may be preferred, with homomeric assembly occurring only in cases of massive overexpression caused by experimental manipulation.
The proposed 3:1 stoichiometry of PKD2 to TRPC1 is supported by single-channel conductance studies, where mean currents of −2.14 + − 0.1 pA are observed upon intranuclear injection of cDNA of PKD2 and TRPC1 at a 3:1 ratio [28] . In contrast, when the ratio of cDNA is 1:1, the channels segregate into two groups, one with mean unitary currents similar to currents obtained when the RNA ratio was 3:1, and the other with mean current amplitudes at −40 mV of −0.9 pA, a value similar to that observed in control patches that contain only TRPC1 [28] . Further evidence that PKD2 favours a trimeric aggregation state within a heterotetrameric setting has recently been reported [32a] . Using single-molecule optical studies in Xenopus oocytes, Yu et al. [32a] show that the full-length PKD2-PKD1 complex exists in a 3:1 stoichiometry. Furthermore, these authors have determined the crystal structure of a truncation (Gly 833 -Gly 895 ) containing the region termed PKD2-CC2 in the present study (Phe 839 -Ala 873 ). They found this region to be trimeric, with the same 'a' and 'd' residue assignments that we have given.
It is pertinent to note that our conclusions and those of Yu et al. [32a] are in contrast with results from two other groups [32b,56] . These latter groups employing full-length Cterminal domains conclude that they form either dimers [56] or a mixture of dimers and monomers [32b] . However, both of these groups rely on data produced by methods that have significant limitations in determining aggregation states due to shape effects of proteins, namely SV analytical ultracentrifugation and sizeexclusion chromatography. Although Giamarchi et al. [32b] claim to have determined the mass of the CRD by sedimentation equilibrium analysis, a method independent of molecular shape, their publication does not show sedimentation equilibrium data, which makes it difficult to evaluate the results. Furthermore, the chemically cross-linked proteins were analysed only by SDS/PAGE and not by MS, which would have given them a true mass instead of estimations of mass based on comparisons with mobility of globular protein standards. The results of the present study show that the CRDs have an anomalous mobility on SDS/PAGE which probably results from the high net negative charge (−18 per monomer) (Figure 2) . Furthermore, data in the present study and those of Yu et al. [32a] are based on shapeindependent methods, such as SLS analysis and chemical crosslinking coupled to MS. Despite the above-mentioned limitations of techniques to determine stoichiometry, an important distinction does exist, namely that Celic et al. [56] and Giamarchi et al. [32b] used full-length CRDs, whereas Yu et al. [32a] and ourselves in the present study used truncated versions of CRDs Asn 681 -Gln 924 and Gly 821 -Ser 926 respectively. Although, as suggested by Giamarchi et al. [32b] , it is conceivable that the C-terminal 42 residues of PKD2 somehow influence the conversion of trimeric CC2 into a dimeric aggregation state, available data argues against it for the following reasons. First, the sequence conservation between PKD2 and PKD2L1 channels in the C-terminus is very low, whereas the CC2 regions are highly conserved. Secondly, the trimeric aggregation state observed at low protein concentrations (1.6 μM) indicates a strong propensity to form trimers driven by CC2. Lastly, our studies show murine PKD2L1-198, representing the full-length CRD, forms trimers even when it is naturally missing the C-terminal 44 residues present in PKD2. Such PKD2L1 molecules form functional channels [15] .
In conclusion, the present study demonstrates that: (i) binding of Ca 2+ has no effect on the oligomerization state of CRDs; (ii) the CRDs form trimers over a range of protein concentrations (1.66-43 μM); (iii) the 36-residue CC2 is the sole determinant driving trimeric assembly of CRDs; and (iv) the trimeric assembly of PKD2 and PKD2L1 CRDs is probably a property intrinsic to all channel-forming polycystins. The trimeric aggregation state of PKD2L1 suggests that the sour-taste receptor PKD2L1-PKD1L3 complex probably exists with a 3:1 stochiometry. These studies raise some interesting questions. Are cation-conducting pores in PKD2 and PKD2L1 homomeric channels trimers or tetramers? And if they assemble as trimers when homo-oligomeric, and tetramers when they are hetero-oligomeric, how does the cation selectivity differ?
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